How to solve the big challenges of cell and gene therapy manufacturing
There has never been more investment and excitement around the cutting-edge medicine being developed under the umbrella of cell and…
There has never been more investment and excitement around the cutting-edge medicine being developed under the umbrella of cell and…
With GlobalData currently forecasting that the data and analytics market in pharma will reach $2.1bn by 2028, real-world data is…
The cell and gene therapy (CGT) market is forecast to be worth almost $80bn by 2030, but issues must be…
In today’s data-driven healthcare landscape, the ability to link disparate datasets is revolutionizing research and care delivery. As the global…
With tighter budgets, regulatory challenges, and uncertainty from tariffs, pharmaceutical companies are turning to third-party logistics (3PL) suppliers to deliver…
A robust supply chain is the backbone of stable growth, making it a critical area of concern for small pharma…
Only 9% of life sciences professionals understand U.S. and EU artificial intelligence (AI) regulations well.[1] Let that sink in. While your…
As the focus on personalized, equitable healthcare continues to intensify, social determinants of health (SDoH) have attracted significant attention in…
As the focus on personalized, equitable healthcare continues to intensify, social determinants of health (SDoH) have attracted significant attention in…
The evolution of pharmaceutical manufacturing is driven largely by the rising demands facing the industry. Inflation, strict regulations and a…